Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL083813-05
Application #
8379448
Study Section
Special Emphasis Panel (ZHL1-CSR-A)
Project Start
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
5
Fiscal Year
2012
Total Cost
$594,659
Indirect Cost
$86,890
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Diffenderfer, Margaret R; Lamon-Fava, Stefania; Marcovina, Santica M et al. (2016) Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). Metabolism 65:381-90
Ikezaki, Hiroaki; Ai, Masumi; Schaefer, Ernst J et al. (2016) Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study. Sci Rep 6:36725
Elajami, Tarec K; Colas, Romain A; Dalli, Jesmond et al. (2016) Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J 30:2792-801
Welty, Francine K; Alfaddagh, Abdulhamied; Elajami, Tarec K (2016) Targeting inflammation in metabolic syndrome. Transl Res 167:257-80
Avadhani, Radhika; Fowler, Kristen; Barbato, Corinne et al. (2015) Glycemia and cognitive function in metabolic syndrome and coronary heart disease. Am J Med 128:46-55
Anthanont, Pimjai; Asztalos, Bela F; Polisecki, Eliana et al. (2015) Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux. J Clin Lipidol 9:390-5
Hegele, Robert A; Gidding, Samuel S; Ginsberg, Henry N et al. (2015) Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. Arterioscler Thromb Vasc Biol 35:2269-80
Rubin, Mishaela R; Goldfine, Allison B; McMahon, Donald J et al. (2015) Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine 50:504-7
Kim, Seoyoung C; Schneeweiss, Sebastian; Glynn, Robert J et al. (2015) Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. Ann Rheum Dis 74:1968-75
Le, Ngoc-Anh; Diffenderfer, Margaret R; Thongtang, Nuntakorn et al. (2015) Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner. Lipids 50:447-58

Showing the most recent 10 out of 58 publications